Reduced expression of PLC-gamma during the differentiation of mouse F9 teratocarcinoma cells

Cancer Lett. 1993 Feb;68(2-3):237-42. doi: 10.1016/0304-3835(93)90152-y.

Abstract

Expression of phosphoinositide-specific phospholipase C (PLC)-gamma during the retinoic acid (RA)-induced differentiation of F9 teratocarcinoma stem cells was investigated. PLC-gamma activity and PLC-gamma protein content were decreased during the differentiation of F9 teratocarcinoma stem cells induced by a combination (RACT) of RA, dibutyryl cyclic AMP (C) and theophylline (T). However, PLC-gamma activity and protein levels in RA- or C- and T-treated F9 cells remained the same as that of the F9 stem cells. Northern analysis of the 5.4-kb PLC-gamma transcript in differentiated F9 cells by RACT revealed that RACT decreased the PLC-gamma gene expression. These results suggest that the expression of PLC-gamma is negatively controlled by RACT treatment in the differentiation of F9 teratocarcinoma stem cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Northern
  • Blotting, Western
  • Bucladesine / pharmacology
  • Cell Differentiation
  • Gene Expression Regulation, Neoplastic
  • Mice
  • Phosphatidylinositol Diacylglycerol-Lyase
  • Phosphoric Diester Hydrolases / biosynthesis*
  • Teratoma / metabolism*
  • Teratoma / pathology
  • Theophylline / pharmacology
  • Tretinoin / pharmacology
  • Tumor Cells, Cultured

Substances

  • Tretinoin
  • Bucladesine
  • Theophylline
  • Phosphoric Diester Hydrolases
  • Phosphatidylinositol Diacylglycerol-Lyase